Received Dec 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
Pharmacist reported that a 33 year old female patient received her first dose of GARDASIL 9 in 2017. She missed her remaining doses.; No symptoms reported; no additional AE; This spontaneous report was received from a Pharmacist and refers to a 33-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. In 2017, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), Suspension for injection (lot # and expiration date were not reported) for prophylaxis. She missed her remaining doses (Inappropriate schedule of product administration). No symptoms reported; no additional AE (no adverse event). Lot # is being requested and will be submitted if received.